Cancer and aging: A model for the cancer promoting effects of the aging stroma

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 11, 2002, Pages 1401-1414

  Krtolica, Ana ^a   Campisi, Judith ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Antagonistic pleiotropy; Cellular senescence; Oncogenic mutations; Tissue microenvironment; Tumor suppression

Indexed keywords

AGING; ANIMAL CELL; CANCER; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENESIS; CELL AGING; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PHENOTYPE; PLEIOTROPY; REVIEW; SENESCENCE; SPECIES DIFFERENCE; STROMA; TISSUE REGENERATION; TUMOR PROMOTION;

AGE FACTORS; AGING; ANIMALS; CELL AGING; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; NEOPLASMS; PHENOTYPE; STROMAL CELLS;

MAMMALIA;

EID: 0036829090     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00053-5     Document Type: Review

References (125)

1. Scott R.E., Tzen C.Y., Witte M.M., Blatti S., Wang H. Regulation of differentiation, proliferation and cancer suppressor activity. Int. J. Dev. Biol. 37:1993;67-74.
2. Lassar A.B., Skapek S.X., Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:1994;788-794.
3. Weinberg R.A. Tumor suppressor genes. Science. 254:1991;1138-1146.
4. Macleod K. Tumor suppressor genes. Curr. Opin. Genet. Dev. 10:2000;81-93.
5. Balducci L., Beghe C. Cancer and age in the USA. Crit. Rev. Oncol. Hematol. 37:2001;137-145.
6. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
7. Balducci L., Lyman G.H. Cancer in the elderly. Epidemiologic and clinical implications. Clin. Geriatr. Med. 13:1997;1-14.
8. Miller R.A. Gerontology as oncology: research on aging as a key to the understanding of cancer. Cancer. 68:1991;2496-2501.
9. Martin G.M. Somatic mutagenesis and antimutagenesis in aging research. Mutat. Res. 350:1966;35-41.
10. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:2000;641-645.
11. Compagni A., Christofori G. Recent advances in research on multistage tumorigenesis. Br. J. Cancer. 83:2000;1-5.
12. Wu X., Pandolfi P. Mouse models for multistep tumorigenesis. Trends Cell Biol. 11:2001;2-9.
13. Sutherland R.M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 240:1988;177-184.
14. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
15. R. Pili, Y. Guo, J. Chang, H. Nakanishi, G.R. Martin, A. Passaniti, Altered angiogenesis underlying age-dependent changes in tumor growth, J. Natl. Cancer Inst. (1994) 1303-1314.
16. Marinho A., Soares R., Ferro J., Schmitt L.M.F.C. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol. Res. Pract. 193:1997;267-273.
17. Bishop J.M. Cancer: the rise of the genetic paradigm. Genes Dev. 9:1995;1309-1315.
18. Deng G., Lu Y., Zlotnikov G., Thor A.D., Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science. 274:1996;2057-2059.
19. Jonason A.S., Kunala S., Price G.T., Restifo R.J., Spinelli H.M., Persing J.A., Leffell D.J., Tarone R.E., Brash D.E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14025-14029.
20. Dolle M.E., Snyder W.K., Gossen J.A., Lohman P.H.M., Vijg J. Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8403-8408.
21. Dollé M.E., Giese H., Hopkins C.L., Martus H.J., Hausdorff J.M., Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:1997;431-434.
22. Knudson A.G. Chasing the cancer demon. Annu. Rev. Genet. 34:2000;1-19.
23. Gray J.W., Collins C. Genome changes and gene expression in human solid tumors. Carcinogenesis. 21:2000;443-452.
24. Loeb L.A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res. 72:1998;25-56.
25. Cahill D.P., Kinzier K.W., Vogeistein B., Lenganer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 9:1999;M57-M60.
26. Aubele M., Mattis A., Zitzelsberger H., Walch A., Kremer M., Welzl G., Hofler H., Werner M. Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int. J. Cancer. 85:2000;82-86.
27. Umayahara K., Numa F., Suchiro Y., Sakata A., Nawata S., Ogata H., Suminami Y., Sakamoto M., Sasaki K., Kato H. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer. 33:2002;98-102.
28. Park C.C., Bissell M.J., Barcellos-Hoff M.H. The influence of the microenvironment on the malignant phenotype. Mol. Med. Today. 6:2000;324-329.
29. Shay J.W., Van Der Haegen B.A., Ying Y., Wright W.E. The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp. Cell Res. 209:1993;45-52.
30. Shay J.W., Wright W.E., Brasiskyte D., Van der Haegen B.A. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene. 8:1993;1407-1413.
31. McDougall J.K. Immortalization and transformation of human cells by human papillomavirus. Curr. Top. Microbiol. Immunol. 186:1994;101-119.
32. Yeager T.R., DeVries S., Jarrard D.F., Kao C., Nakada S.Y., Moon T.D., Bruskewitz R., Stadler W.M., Meisner L.F., Golchrist K.W., Newton M.A., Waidman F.M., Reznikoff C. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12:1998;163-174.
33. Romanov S.R., Kozakiewicz B.K., Hoist C.R., Stampfer M.R., Haupt L.M., Tisty T.D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 409:2001;633-637.
34. llmensee K. Reversion of malignancy and normalized differentiation of teratocarcinoma cells in chimeric mice. Basic Life Sci. 12:1978;3-25.
35. Sachs L. The cellular and molecular environment in leukemia. Blood Cells. 19:1993;709-726.
36. Boudreau N., Reddy S.T., Stoker A.W., Fairman C., Bissell M.J. The embryonic environment and extracellular matrix suppress oncogenic transformation by Rous sarcoma virus in chick embryos. Mol. Cell. Diff. 3:1995;261-274.
37. Kiemerman D.I., Dinney C.P., Zhang W.W., Lin S.H., Van N.T., Hsieh J.T. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res. 56:1996;3431-3435.
38. McCullough D., Coleman W.B., Smith G.J., Grisham J.W. Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res. 57:1997;1807-1813.
39. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Damsky B.P.C., Bissell M.J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:1997;231-245.
40. McCullough K.D., Coleman W.B., Ricketts S.L., Wilson J.W., Smith G.J., Grisham J.W. Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc. Natl. Acad. Sci. U.S.A. 95:1998;15333-15338.
41. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature. 411:2001;375-379.
42. van den Hoof A. Stromal involvement in malignant growth. Adv. Cancer Res. 50:1998;159-196.
43. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., D P., Bissell M.J., Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:1999;137-146.
44. Barcellos-Hoff M.H., Ravani S.A. Irradiated mammary gland stroma promotes expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60:2000;1254-1260.
45. Donjacour A.A., Cunha G.R. Stromal regulation of epithelial function. Cancer Treat. Res. 53:1991;335-364.
46. Tlsty T.D., Hem P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11:2001;54-59.
47. Chrenek M.A., Wong P., Weaver V.M. Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3:2001;224-229.
48. Skobe M., Fusenig N.E. Tumorigenic conversion of immortal human keratinocytes through stromal activation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1050-1055.
49. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59:1999;5002-5011.
50. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:1965;614-636.
51. Stanulis-Praeger B. Cellular senescence revisited: a review. Mech. Ageing Dev. 38:1987;1-48.
52. Cristofalo V.J., Pignolo R.J. Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev. 73:1993;617-638.
53. J. Campisi, G.P. Dimri, E. Hara, Control of replicative senescence, in: E. Schneider, J. Rowe (Eds.), Handbook of the Biology of Aging, Academic Press, New York, 1996, pp. 121-149.
54. Chiu C.P., Harley C.B. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc. Soc. Exp. Biol. Med. 214:1997;99-106.
55. Shay J.W., Wright W.E. Telomeres and telomerase: implications for cancer and aging. Radiat. Res. 155:2001;188-193.
56. Campisi J., Kim S., Lim C., Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 36:2001;1619-1637.
57. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573.
58. Levy M.Z., Allsopp R.C., Futcher A.B., Greider C.W., Harley C.B. Telomere end-replication problem and cell aging. J. Mol. Biol. 225:1992;951-960.
59. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature. 345:1990;458-460.
60. Wright W.E., Shay J.W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11:2001;98-103.
61. Blackburn E.H. Telomere states and cell fates. Nature. 408:2000;53-56.
62. de Lange T. Telomere capping - one strand fits all. Science. 292:2001;1075-1076.
63. Lingrier J., Cech T.R. Telomerase and chromosome end maintenance. Curr. Opin. Genet. Dev. 8:1998;226-232.
64. Collins K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:2000;378-383.
65. Weng N.P., Hodes R.J. The role of telomerase expression and telomere length maintenance in human and mouse. J. Clin. Immunol. 20:2000;257-267.
66. Nugent C.I., Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1998;1073-1085.
67. Reddel R.R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis. 21:2000;477-484.
68. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
69. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germime and embryonic tissues and cells. Dev. Genet. 18:1996;173-179.
70. Wei S., Wei S., Sedivy J.M. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1999;1539-1543.
71. Chang B.D., Broude E.V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E.S., Lausch E., Christov K., Roninson I.B. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59:1999;3761-3767.
72. DiLeonardo A., Linke S.P., Clarkin K., Wahl G.M. DNA damage triggers a prolonged p53-dependent Gi arrest and long-term induction of Cipi in normal human fibroblasts. Genes Dev. 8:1994;2540-2551.
73. Chen Q., Fischer A., Reagan J.D., Yan L.J., Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4337-4341.
74. Robles S.J., Adami G.R. Agents that cause DNA double strand breaks lead to pl6INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 16:1998;1113-1123.
75. Ogryzko V.V., Hirai T.H., Russanova V.R., Barbie D.A., Howard B.H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:1996;5210-5218.
76. Bertram M.J., Berube N.G., Hang-Swanson X., Ran Q., Leung J.K., Bryce S., Spurgers K., Bick R.J., Baldini A., Ning Y., Clark L.J., Parkinson E.K., Barrett J.C., Smith J.R., Pereira-Smith O.M. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor genes. Mol. Cell. Biol. 19:1999;1479-1485.
77. Cairns B. Emerging roles for chromatin remodeling in cancer biology. Trends Cell Biol. 11:2001;15-21.
78. Wade P.A. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum. Mol. Genet. 18:2001;693-698.
79. Ridley A.J., Paterson H.F., Noble M., Land H. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7:1988;1635-1645.
80. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and pl6INK4a. Cell. 88:1997;593-602.
81. Sewing A., Wiseman B., Lloyd A.C., Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21/Cipl. Mol. Cell. Biol. 17:1997;5588-5597.
82. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 12:1998;2997-3007.
83. Dirnri G.P., Itahana K., Acosta M., Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14IARF tumor suppressor. Mol. Cell. Biol. 20:2000;273-285.
84. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35:2000;317-329.
85. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:2000;705-709.
86. Itahana K., Dimri G., Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem. 268:2001;2784-2791.
87. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:2001;27-31.
88. Sager R. Senescence as a mode of tumor suppression. Environ. Health Perspect. 93:1991;59-62.
89. Donehower L.A., Harvey M., Slagke B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
90. Harvey M., Sands A.T., Weiss R.S., Hegi M.E., Wiseman R.W., Pantazis P., Giovanella B.C., Tainsky M.A., Bradley A., Donehower L.A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 8:1993;2457-2467.
91. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4A locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
92. Ohebranious N., Donehower L.A. Mouse models in tumor suppression. Oncogene. 17:1998;3385-3400.
93. de Boer J., Hoeij makers J. Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair. Biochimie. 81:1999;127-137.
94. Artandi S.E., DePinho R.A. Mice without telomerase: what can they teach us about human cancer? Nat. Med. 6:2000;852-855.
95. Hayflick L. Human cells and aging. Sci. Am. 218:1968;32-37.
96. Smith J.R., Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science. 273:1996;63-67.
97. Campisi J. From cells to organisms: can we learn about aging from cells in culture? Exp. Gerontol. 36:2001;607-618.
98. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J. Am. Geriatr. Soc. 45:1997;1-6.
99. Rinehart C.A., Torti V.R. Aging and cancer: the role of stromal interactions with epithelial cells. Mol. Carcinog. 18:1997;187-192.
100. Campisi J. Cancer aging cell, Senescence In Vivo. 14:2000;183-188.
101. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O.M., Peacocke M., Campisi J. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9363-9367.
102. Homsby P.J., Hancock J.P., Vo T.P., Nason L.M., Ryan R.F., McAllister J.M. Loss of expression of a differentiated function gene, steroid 17a-hydroxylase, as adrenocortical cells senesce in culture. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1580-1584.
103. West M.D., Pereira-Smith O.M., Smith J.R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 184:1989;138-147.
104. Millis A.J.T., Hoyle M., McCue H.M., Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in diploid human fibroblasts. Exp. Cell Res. 201:1992;373-379.
105. Linskens M.H.K., Feng J., Andrews W.H., Enlow B.E., Saati S.M., Tonkin L.A., Funk W.D., Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucl. Acids Res. 23:1995;3244-3251.
106. Maier J.A.M., Voulalas P., Roeder D., Maciag T. Extension of the life-span of human endothelial cells by an interleukin-la antisense oligomer. Science. 249:1990;1570-1574.
107. Vasile E., Tomita Y., Brown L.F., Dvorak H.F., Kocher O. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15:2001;458-466.
108. Campisi J. Replicative senescence: an old lives tale? Cell. 84:1996;497-500.
109. Harley C.B. Human ageing and telomeres. Ciba Found. Symp. 211:1997;129-139.
110. Hodes R.J. Telomere length, aging and somatic cell turnover. J. Exp. Med. 190:1999;153-156.
111. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247.
112. Barnett Y.A., Barnett C.R., Von Zglinicki T. DNA damage and telomere length in human T cells. J. Anti-Aging Med. 3:2000;383-388.
113. Howard B.H. Replicative senescence: considerations relating to the stability of heterochromatin domains. Exp. Gerontol. 31:1996;281-293.
114. Villeponteau B. The heterochromatin loss model of aging. Exp. Gerontol. 32:1997;383-394.
115. Kitano H., Imai S. The two-process model of cellular aging. Exp. Gerontol. 33:1998;393-419.
116. Kirkwood T.B., Austad S.N. Why do we age? Nature. 408:2000;233-238.
117. Stanley A., Osler T. Senescence and the healing rates of venous ulcers. J. Vasc. Surg. 33:2001;1206-1211.
118. Pendergrass W.R., Lane M.A., Bodkin N.L., Hansen B.C., Ingram D.K., Roth G.S., Yi L., Bin H., Wolf N.S. Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta). J. Cell. Physiol. 180:1999;123-130.
119. Mishima K., Handa J.T., Aotaki-Keen A., Lutty G.A., Morse L.S., Hjelmeland L.M. Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest. Ophthalmol. Vis. Sci. 40:1999;1590-1593.
120. Paradis V., Youssef N., Dargere D., Ba N., Bonvoust F., Bedossa P. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol. 32:2001;327-332.
121. Ding G., Franki N., Kapasi A.A., Reddy K., Gibbons N., Singhal P.C. Tubular cell senescence and expression of TGF-betal and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp. Mol. Pathol. 70:2001;43-53.
122. Choi J., Shendrik I., Peacocke M., Peehl D., Buttyan R., Ikeguchi E.F., Katz A.E., Benson M.C. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology. 56:2000;160-166.
123. Fenton M., Barker S., Kurz D.J., Erusalimsky J.D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler. Thromb. Vasc. Biol. 21:2001;220-226.
124. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11190-11194.
125. Krtolica A., Parrinello S., Lockett S., Desprez P., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12072-12077.